Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Plasticell Announces Grant of Fundamental CombiCult™ Patents in USA and Japan

Published: Tuesday, February 14, 2012
Last Updated: Tuesday, February 14, 2012
Bookmark and Share
Patents have now been issued in Europe, USA, Japan, Australia and Singapore.

Plasticell has announced that patents for its combinatorial cell culture platform technology, CombiCult™, have been granted in the USA and Japan. Patents covering CombiCult™ have now been issued in Europe, USA, Japan, Australia and Singapore.

CombiCult™ breaks the major bottleneck in stem cell research and development programmes - the discovery of optimized stem cell differentiation protocols.

CombiCult™ also allows scientists to develop custom cell culture media (e.g. GMP compatible stem cell expansion media for cell therapy), create high value cell lines for toxicity testing in the pharmaceutical/cosmetic/nutrition industries, and to increase yield and/or decrease cost of bioprocess manufacturing.

“Plasticell’s proprietary technology breaks the major bottleneck in current stem cell research. Having followed CombiCult™’s development for almost a decade, I am delighted that the importance of this revolutionary technology is now being recognized through multiple industry awards and patents”, commented Sir Martin Evans FRS, a founding member of Plasticell’s Scientific Advisory Board and recipient of the Nobel prize for the isolation of embryonic stem cells.

Dennis Saw, CEO of Plasticell added, “Since 2002, Plasticell has continually innovated and expanded intellectual property coverage to secure its leading position in the stem cell space. Granted patents in the USA, Europe and Japan mean that the CombiCult™ process, which underlies many of our technologies, is now protected in all the major biotech markets which we operate in.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Plasticell Appoints Dr Aaron T. T. Chuang as Chief Scientific Officer
New appointment further strengthens the company’s expertise in regenerative medicine product development.
Tuesday, June 16, 2015
Plasticell Wins Innovate UK Funding
Funding for £1.6 million cord blood stem cell manufacturing project.
Friday, February 06, 2015
Plasticell Signs Deal with JCR Pharmaceuticals
Collaboration agreement to use CombiCult® stem cell technology in Japan.
Tuesday, February 25, 2014
Additional Family of CombiCult® Patents Granted in USA, Europe, Australia and Singapore
Newly granted patents cover the use of nanomaterial tags.
Tuesday, November 19, 2013
Plasticell and EMD Millipore Complete Licensing Deal
Deal to distribute fully defined, xeno-free mesenchymal stem cell differentiation media.
Tuesday, January 01, 2013
Plasticell and Veritas Announce an Exclusive Distribution Agreement in Japan
Veritas engaged as exclusive distributor for Plasticell’s services and products, including CombiCult®.
Monday, June 18, 2012
Plasticell Wins Further Funding for Stem Cell Manufacturing Project
Technology Strategy Board will provide a grant of approximately £750k towards a £1.5m project.
Wednesday, December 14, 2011
Plasticell Delivers Differentiation Protocols to Stemnion, Inc.
Plasticell announces successful completion of a collaboration with Stemnion, Inc..
Tuesday, August 09, 2011
Plasticell Spins Out Regenerative Drug Discovery Venture
New demerged business called ‘Progenitor Labs’.
Thursday, April 14, 2011
Plasticell Completes £3.5 Million Financing Round
Capital injection to expand business development and marketing initiatives to increase growing customer base.
Wednesday, February 16, 2011
Plasticell Signs Technology Agreement with Sigma-Aldrich
Collaboration to produce novel turnkey solution for stem cell research.
Monday, November 29, 2010
Plasticell Signs Stem Cell Research Collaboration with UCB
Plasticell will screen UCB’s drug compound libraries using CombiCult™ technology to discover new cell signaling pathways involved in stem cell biology.
Tuesday, November 09, 2010
Plasticell Signs Collaboration with UCB
First in kind deal to partner small molecule drugs for stem cell research.
Monday, November 08, 2010
Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!